Cargando…
Corrigendum to: Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084092/ https://www.ncbi.nlm.nih.gov/pubmed/36722017 http://dx.doi.org/10.1093/ehjcvp/pvad011 |
Ejemplares similares
-
Association between use of novel glucose-lowering drugs and COVID-19
hospitalization and death in patients with type 2 diabetes: a nationwide registry
analysis
por: Ferrannini, Giulia, et al.
Publicado: (2022) -
Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study [Corrigendum]
Publicado: (2018) -
Corrigendum to “Correlation between lower extremity arterial disease and skeletal muscle mass in patients with type 2 diabetes mellitus”
Publicado: (2020) -
Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
Publicado: (2017) -
Corrigendum to “Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes”
por: Fu, Yuanyuan, et al.
Publicado: (2022)